Sio Gene Therapies Inc.

CIK 1636050 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sio Gene Therapies Inc..

Recent SEC filings

FiledFormAccession number
Apr 25, 202315-12G0001636050-23-000028
Apr 24, 2023EFFECT9999999995-23-001018
Apr 17, 2023S-8 POS0001636050-23-000024
Apr 17, 2023POS AM0001636050-23-000026
Apr 12, 202325-NSE0001354457-23-000271
Apr 6, 20238-K0001636050-23-000016
Apr 6, 2023250001636050-23-000017
Mar 17, 2023DEFA14A0001636050-23-000013
Mar 15, 20238-K0001636050-23-000011
Feb 21, 2023DEFM14A0001140361-23-007830
Feb 14, 20238-K0001636050-23-000008
Feb 14, 2023DEFA14A0001636050-23-000009
Feb 14, 202310-Q0001636050-23-000007
Feb 13, 2023SC 13G/A0000919574-23-000939
Feb 10, 2023SC 13G0001104659-23-018477
Feb 9, 2023PREM14A0001140361-23-005279
Dec 14, 20228-K0001636050-22-000054
Dec 14, 2022DEFA14A0001636050-22-000056
Nov 10, 20228-K0001636050-22-000051
Nov 10, 202210-Q0001636050-22-000050
Sep 14, 20228-K0001636050-22-000043
Aug 11, 20228-K0001636050-22-000041
Aug 11, 202210-Q0001636050-22-000040
Jun 14, 202210-K0001636050-22-000035
Jun 14, 20228-K0001636050-22-000036